Compare BioNTech SE - ADR (BNTX) vs Kimberly Clark Corp (KMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Kimberly Clark Corp — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Kimberly Clark Corp trades at $108.02 (market cap $36.11B). The key difference: Kimberly Clark Corp is the larger of the two by market cap, and Kimberly Clark Corp pays a 4.72% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | KMB | |
|---|---|---|
Market Cap | $23.31B | $36.11B |
Sector | Health | Consumer Staples |
52-Week High | $119.34 | $134.81 |
52-Week Low | $83.89 | $93.05 |
Enterprise Value | $6.60B | $41.67B |
Dividend Yield | — | 4.72% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Kimberly Clark Corp
With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →
